Leader of the Oxford University and AstraZeneca-backed trial, Professor Andrew Pollard says the team is ‘optimistic’ about getting the go-ahead for the ‘miracle’ vaccine by Christmas time. The academic says their anti-viral would be ten times cheaper than Pfizer ‘s product – which requires two injections several weeks apart and has to be stored at -78C. He says their vaccine is stored at ‘fridge temperature’ and is very close to demonstrating ‘efficacy’ – which Pfizer proved on its own version on Monday. It comes after the Government said a further 462 people had died within 28 days of testing positive for Covid-19 as of Saturday. As of 9am on Saturday, there had been a further 26,860 lab-confirmed cases of coronavirus in the UK, slightly down from 27,301 on Friday. Pictured right: AstraZeneca offices.
Original Article:
Original Video:
Daily Mail Facebook:
Daily Mail IG:
Daily Mail Snap:
Daily Mail Twitter:
Daily Mail Pinterest:
Daily Mail Google+:
Get the free Daily Mail mobile app:
